GSK3B and glioblastoma: One recent study found that GSK3β palmitoylation, mediated by ZDHHC4, decreases p-Ser9 and increases p-Tyr216, leading to continuous activation of GSK3β, promoting tumorigenicity of glioblastoma stem cells.131